Related Experiment Video
Updated: Apr 8, 2026

Meta-Analysis of the Effectiveness and Safety of Shugan Jieyu Capsules for the Treatment of Insomnia
Published on: February 17, 2023
Diabetes modifies the association between magnesium and insomnia, but not depressive symptomatology, in Puerto Rican
Fan Chen1, Kelsey M Mangano2, Tammy M Scott3
1Department of Biomedical and Nutritional Sciences, Zuckerberg College of Health Sciences, University of Massachusetts Lowell, Lowell, MA, United States; Department of Nutrition and Food Hygiene, School of Public Health, Institute of Nutrition, Fudan University, Shanghai, People's Republic of China.
Background:
Evidence on magnesium (Mg), depression, and sleep quality has been controversial.
Objectives:
We aimed to examine associations of serum and dietary Mg with depressive and insomnia symptoms in a prospective longitudinal cohort.
Methods:
Adults from the Boston Puerto Rican Health Study who completed the Centre for Epidemiologic Studies Depression Scale (CES-D) assessment at any visit from baseline to the third visit (∼6-y follow-up) were included in analyses on Mg and depressive symptomatology (n = 1465 with Mg intake; n = 1116 with serum Mg). Linear mixed-effects models were used to estimate β coefficients and 95% confidence intervals (CI). Mg measures at visit 2 were used to predict incident insomnia symptoms at visit 3 (n = 613 with Mg intake; n = 587 with serum Mg; median follow-up: ∼4 y). Logistic regression was used to estimate odds ratios (ORs). Diabetes, sex, baseline Mg status, and calcium:Mg intake ratio were evaluated as modifiers.
Results:
No clear association was observed between Mg and CES-D score after adjustment for confounders. However, higher Mg intake from food was associated with less low positive affect, a dimension of CES-D [β (95% CI): -0.28 (-0.45, -0.11)]. Mg was not associated with insomnia in the full sample. However, higher Mg intake and supplement use were associated with lower odds of insomnia in participants without diabetes [per 100 mg/d total Mg: OR (95% CI): 0.42 (0.23, 0.79); per 100 mg/d Mg from food: 0.41 (0.21, 0.79); Mg supplement users compared with nonusers: 0.37 (0.17, 0.81)], which was not found in participants with diabetes (P-interaction < 0.05). Serum Mg was not associated with either outcome. Limited interaction was detected for other potential modifiers, despite some subgroup variation in association direction or magnitude.
Conclusions:
Higher Mg intake was associated with lower odds of insomnia symptoms in Puerto Rican adults without diabetes. Further research is needed to investigate the role of diabetes in the Mg-sleep association.
Related Concept Videos
Management of Insomnia
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Diabetes Mellitus: Type 2 and Gestational
Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
Insomnia
Multiple factors contribute...
Psychoneuroimmunology: Diabetes and Cancer

